In line with previous research, we demonstrated that both men with LP/P BRCA1 and BRCA2 variants are at a high risk of prostate cancer diagnosis, with the highest risk among men carrying LP/P variants in BRCA2 [21, 30]. This evidence concerns the gene BRCA2 and prostate cancer.